The Carcinoid Cancer Foundation is pleased to announce that Aman Chauhan, MD, is the NET expert for CCF’s Ask the NET Expert program during April 2022. Launched in February, Ask the NET Expert is a web-based program* for the neuroendocrine tumor community featuring a different NET experts .
Dr. Chauhan, a medical oncologist, is Director of NET Theranostics at UK Markey Cancer Center in Kentucky. His clinical interests focus on the full spectrum of neuroendocrine cancers, including carcinoid tumors, high-grade neuroendocrine carcinomas and small cell lung cancer. As Markey’s Director of NET Theranostics, Dr. Chauhan identifies NET patients who qualify for Lutathera® (Lutetium 177 DOTATATE) treatments for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Dr. Chauhan is also co-director of the multidisciplinary Pediatric Neuroendocrine Tumor Clinical and Research Program at the Kentucky Children’s Hospital.
Dr. Chauhan completed a Cancer Therapy Evaluation Program (CTEP) physician externship at the National Cancer institute (NCI) that focused on designing clinical trials and clinical research projects. He was selected to join NET Connect, an international organization that brings NET experts together and includes strategic support from a steering committee of established leaders in the field. Dr. Chauhan is principal investigator on multiple investigator initiated clinical trials including NCI sponsored multi-center Phase I studies.
He is a member of the American Society of Clinical Oncology as well as the American Association of Cancer Research and the North American Neuroendocrine Tumor Society.
Among Dr. Chauhan’s recent articles are:
- How I Treat Neuroendocrine Tumors
- Management of Large Cell Neuroendocrine Carcinoma
- Management of Bronchopulmonary Neuroendocrine Tumors
- hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
To read more about the clinical trials for which Dr. Chauhan is the Principal Investigator, click here.
Read more about the Neuroendocrine Tumor program at UK Markey Cancer Center.
QUESTIONS AND ANSWERS, PART 1
QUESTIONS AND ANSWERS, PART 2
*The opinions expressed by NET experts, as well as the questions posed, haven’t been created or suggested by the Carcinoid Cancer Foundation, and CCF doesn’t endorse or promote any of the views or information expressed by the NET experts. You should not rely on the opinions expressed by the NET experts but should seek guidance and direction from your own medical advisors regarding any choices you make regarding your health and treatments.
